Professor Matthew Walker and his fellow researchers, at University College London (UCL), have some promising early evidence in epilepsy and NRF2 research. Their research targets two approaches, 1) By targeting anti-oxidant treatments to inhibit the enzymes that produce ROS (Approach A: An attacking approach) and 2) by increasing the ability of neurons to break ROS down… Continue reading New Grant Issued for Nrf2 and Epilepsy Prevention Study